1. The TRPC1 Channel Forms a PI3K/CaM Complex and Regulates Pancreatic Ductal Adenocarcinoma Cell Proliferation in a Ca2+-Independent Manner
   Julie Schnipper et al, 2022, International Journal of Molecular Sciences CrossRef
2. SKF96365 Inhibits Tumor Proliferation by Inducing Apoptosis and Autophagy in Human Esophageal Squamous Cell Carcinoma
   Jiaxin Zhang et al, 2024, International Journal of Genomics CrossRef
3. Design and Synthesis of Newly Synthesized Acrylamide Derivatives as Potential Chemotherapeutic Agents against MCF-7 Breast Cancer Cell Line Lodged on PEGylated Bilosomal Nano-Vesicles for Improving Cytotoxic Activity
   Islam Zaki et al, 2021, Pharmaceuticals CrossRef
4. Comprehensive review on signaling pathways of dietary saponins in cancer cells suppression
   Yifan Zhou et al, 2023, Critical Reviews in Food Science and Nutrition CrossRef
5. Aberrant TRPC1 expression reflects stromal cervical invasion, lymphovascular invasion, elevated FIGO stage, and poor survival in resectable endometrial carcinoma patients
   Yi Wang et al, 2022, Journal of Clinical Laboratory Analysis CrossRef
6. miRNA-186-5p inhibits migration, invasion and proliferation of breast cancer cells by targeting SBEM
   Hui Hao et al, 2023, Aging CrossRef
7. TRPs in Ovarian Serous Cystadenocarcinoma: The Expression Patterns, Prognostic Roles, and Potential Therapeutic Targets
   Cheng Zhang et al, 2022, Frontiers in Molecular Biosciences CrossRef
8. Peptidergic Systems and Cancer: Focus on Tachykinin and Calcitonin/Calcitonin Gene-Related Peptide Families
   Manuel Lisardo Sánchez et al, 2023, Cancers CrossRef
9. Transient receptor potential canonical 1 is a candidate treatment target for tongue squamous cell carcinoma by inhibiting growth and invasion through phosphatidylinositol 3-kinase and protein kinase B pathway
   Bing Zhou et al, 2023, Journal of Oral Science CrossRef
10. From Micro to Long: Non-Coding RNAs in Tamoxifen Resistance of Breast Cancer Cells
    Jéssica Fernanda Barazetti et al, 2021, Cancers CrossRef
11. Robust identification of common genomic biomarkers from multiple gene expression profiles for the prognosis, diagnosis, and therapies of pancreatic cancer
    Md Bayazid Hossen et al, 2023, Computers in Biology and Medicine CrossRef
12. Transient Receptor Potential (TRP) channels in cancer: Implications for drug discovery and development
    Lina Hudhud et al, 2024, TRP Channels as Therapeutic Targets CrossRef
13. Transient Receptor Potential Channel 1 Potentially Serves as a Biomarker Indicating T/TNM Stages and Predicting Long-Term Prognosis in Patients With Renal Cell Carcinoma
    Liang Chen et al, 2022, Frontiers in Surgery CrossRef
14. Smart Design of Mitochondria-Targeted and ROS-Responsive CPI-613 Delivery Nanoplatform for Bioenergetic Pancreatic Cancer Therapy
    Yi-Mei Zhang et al, 2021, Nanomaterials CrossRef
15. Dysregulated transient receptor potential channel 1 expression and its correlation with clinical features and survival profile in surgical non‐small‐cell lung cancer patients
    Changjiang Ke et al, 2022, Journal of Clinical Laboratory Analysis CrossRef
16. Curing pancreatic cancer
    Benno Traub et al, 2021, Seminars in Cancer Biology CrossRef
17. TRPC1 Correlates with Poor Tumor Features, Radiotherapy Efficacy and Survival in Tongue Squamous Cell Carcinoma
    Guang Shi et al, 2022, Biomarkers in Medicine CrossRef
18. The effects of perfluorooctanoic acid on breast cancer metastasis depend on the phenotypes of the cancer cells: An in vivo study with zebrafish xenograft model
    Chi Huang et al, 2024, Environmental Pollution CrossRef
19. Small breast epithelial mucin as a useful prognostic marker for breast cancer patients
    Hui Hao et al, 2023, Open Life Sciences CrossRef
20. TRP Channels in Cancer: Signaling Mechanisms and Translational Approaches
    Matilde Marini et al, 2023, Biomolecules CrossRef
21. Role of Genetic Variation in Cytochromes P450 in Breast Cancer Prognosis and Therapy Response
    Viktor Hlaváč et al, 2021, International Journal of Molecular Sciences CrossRef
22. Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach
    Yee Kit Tai et al, 2022, Frontiers in Oncology CrossRef